Thawing System Market Size (2024 - 2029)

The thawing system market is anticipated to experience substantial growth, driven by the rising demand for thawed cells in disease treatment and the increasing application of thawing devices across various sectors. The market's expansion is further supported by investments in research and development by biotechnology and pharmaceutical companies, focusing on optimizing cryopreservation and freeze-thawing processes. Despite the challenges posed by the high cost of automatic devices, advancements in technology and the integration of thawing systems into broader bioproduction platforms are expected to enhance market size and share. The market's growth trajectory is also influenced by the residual impacts of the COVID-19 pandemic, which highlighted the critical role of thawing systems in vaccine and specimen transport.

Market Size of Thawing System Industry

Thawing System Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 12.80 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Thawing System Market Major Players

*Disclaimer: Major Players sorted in no particular order

Thawing System Market Analysis

The thawing system market studied is expected to register a CAGR of nearly 12.8% over the forecast period.

  • The COVID-19 pandemic had a significant impact on the thawing system market, primarily due to the increased utilization of thawing systems for transporting vaccines and swabs to keep them viable for testing. For example, a December 2022 article published in MedRxiv notes that ultra-low temperature preservation has been the gold standard for the long-term storage of several types of clinical specimens, including the SARS-CoV-2 virus. Frozen specimens are easily transportable and can be analyzed at a later date, and de-identified frozen residual samples can be used in a variety of preclinical and clinical research. 
  • Additionally, freezing and thawing do not significantly affect the testing results when making dilutions or testing clinical samples on rapid test kits. Therefore, COVID-19 had a significant impact on the thawing system market. However, with the resumption of laboratory services and decreasing cases of COVID-19, the studied market is expected to witness stable growth over the forecast period.
  • The major factors driving the growth of the market include increasing usage of thawing devices in various applications and increasing demand for thawed cells for the treatment of different diseases. Furthermore, the growing investments in research and development programs by biotechnology and pharmaceutical companies are boosting market growth. For instance, an April 2022 article published in PubMed suggests that targeted research into optimizing cryopreservation and freeze-thawing routines, as well as the design of adjunct manufacturing processes, may provide critical advantages in improving the safety and efficacy of cellular therapeutics in clinical use. This research also enables effective market deployment strategies to become economically viable and sustainable medicines. 
  • Furthermore, many comparative studies with thawing systems and technological advancements are likely to increase the utilization of the thawing system. For example, in November 2022, BioLife Solutions, Inc., a developer, and supplier of class-defining bioproduction products and services for cell and gene therapy (CGT) and the broader biopharma markets, provided an update on the expansion of its intellectual property estate. The company received notice of the granting of seven patents by the USPTO and other patent authorities outside the United States and filed 43 new applications for novel inventions related to its cell processing, media, storage containers, freezers, and thaw systems platforms, several of which are specific to BioLife's proprietary Stirling engine technologies. 
  • In December 2021, Sartorius and HOF Sonderanlagenbau entered into a partnership to integrate two HOF horizontal plate freeze-thaw units into Sartorius' portfolio, offering customers a full suite of compatible freeze-thaw equipment and consumables. This partnership enabled faster and easier implementation of robust frozen drug substance management platforms through improved validation and purchase support from a single supplier.
  • Thus, with the increase in demand for thawing systems and rapid technological advancements, the studied market is expected to witness significant growth over the forecast period. However, the high cost of automatic devices remains a major drawback to market growth.

Thawing System Industry Segmentation

As per the scope of the report, thawing systems are used for defrosting biological samples such as plasma, stem cells, etc. Thawing refers to the process of taking a frozen product to a temperature where there is no residual ice. This process is also called defrosting and is simply the opposite of freezing.

The thawing system market is segmented by device type (manual devices, automated devices), sample (blood, embryos, ovum, and other samples), end-user (hospitals & diagnostic laboratories, blood banks & transfusion centers, other end-users), and geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally.

The report offers the value (in USD) for the above segments.

By Device Type
Manual Devices
Automated Devices
By Sample
Blood
Embryos
Ovum
Other Samples
By End-User
Hospitals & Diagnostic Laboratories
Blood Banks & Transfusion Centers
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Thawing System Market Size Summary

The thawing system market is poised for substantial growth, driven by increasing applications across various sectors and the rising demand for thawed cells in disease treatment. The market's expansion is further supported by significant investments in research and development by biotechnology and pharmaceutical companies, which are focusing on optimizing cryopreservation and freeze-thawing processes. Technological advancements and comparative studies are enhancing the utilization of thawing systems, with companies like BioLife Solutions and Sartorius making strategic partnerships and innovations to improve their offerings. Despite the high cost of automatic devices posing a challenge, the market is expected to witness robust growth over the forecast period.

North America is anticipated to maintain a significant market share due to its developed infrastructure in blood banks and biobanks, coupled with increasing research activities in regenerative medicine and gene therapy. The region's growth is further bolstered by the rising demand for thawing systems, driven by the need for defrosting stored plasma in blood banks and the launch of new products by key players like Thermo Fisher. The market is consolidated, with major players engaging in strategic initiatives such as partnerships and product launches to enhance their regional presence. As the demand for thawing systems continues to rise, the market is expected to experience notable growth, particularly in North America.

Explore More

Thawing System Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Usage of Thawing System in the Biopharmaceuticals Industry

      2. 1.2.2 Increasing Demand for Thawed Cells

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Automation

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Device Type

      1. 2.1.1 Manual Devices

      2. 2.1.2 Automated Devices

    2. 2.2 By Sample

      1. 2.2.1 Blood

      2. 2.2.2 Embryos

      3. 2.2.3 Ovum

      4. 2.2.4 Other Samples

    3. 2.3 By End-User

      1. 2.3.1 Hospitals & Diagnostic Laboratories

      2. 2.3.2 Blood Banks & Transfusion Centers

      3. 2.3.3 Other End-Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Thawing System Market Size FAQs

The Thawing System Market is projected to register a CAGR of 12.80% during the forecast period (2024-2029)

Sartorius AG, Cardinal Health, Boekel Scientific, Helmer Scientific Inc. and Thermo Fisher Scientific are the major companies operating in the Thawing System Market.

Thawing System Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)